Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.64B P/E 21.80 EPS this Y 2.90% Ern Qtrly Grth -62.50%
Income 67.74M Forward P/E 12.67 EPS next Y 13.20% 50D Avg Chg 6.00%
Sales 1.54B PEG 1.05 EPS past 5Y 7.23% 200D Avg Chg -13.00%
Dividend N/A Price/Book 2.15 EPS next 5Y 8.80% 52W High Chg -27.00%
Recommedations 2.70 Quick Ratio 1.85 Shares Outstanding 78.60M 52W Low Chg 19.00%
Insider Own 13.81% ROA 4.24% Shares Float 67.22M Beta 1.14
Inst Own 88.93% ROE 3.99% Shares Shorted/Prior 2.09M/2.51M Price 44.48
Gross Margin 61.49% Profit Margin 4.39% Avg. Volume 817,158 Target Price 44.40
Oper. Margin 19.12% Earnings Date May 6 Volume 861,998 Change -1.05%
About Integra LifeSciences Holdings C

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Integra LifeSciences Holdings C News
04/18/24 Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
04/18/24 Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
04/17/24 Earnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline
04/09/24 Here's Why Investors Should Retain Integra (IART) Stock Now
04/01/24 Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
03/31/24 Integra LifeSciences Holdings' (NASDAQ:IART) earnings have declined over three years, contributing to shareholders 48% loss
03/29/24 Why Is Integra (IART) Down 4% Since Last Earnings Report?
03/13/24 11 Oversold Healthcare Stocks To Buy Right Now
03/12/24 Integra LifeSciences (IART) Introduces MicroMatrix Flex
03/11/24 Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
03/01/24 Integra LifeSciences Holdings Full Year 2023 Earnings: EPS Misses Expectations
02/29/24 Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript
02/29/24 Integra's (IART) Q4 Earnings Miss Estimates, Margins Down
02/29/24 Integra Lifesciences CEO Jan De Witte to retire
02/28/24 Q4 2023 Integra Lifesciences Holdings Corp Earnings Call
02/28/24 Compared to Estimates, Integra (IART) Q4 Earnings: A Look at Key Metrics
02/28/24 Integra LifeSciences (IART) Misses Q4 Earnings and Revenue Estimates
02/28/24 Integra Lifesciences Reports Subdued Earnings Amidst Market Stability and Product Resilience
02/28/24 Integra LifeSciences Announces Leadership Transition Plan
02/28/24 Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
IART Chatroom

User Image Stock_Titan Posted - 6 days ago

$IART Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024 https://www.stocktitan.net/news/IART/integra-life-sciences-to-reschedule-the-first-quarter-2024-financial-0w4usxgk46hk.html

User Image Villidj_Idjit Posted - 2 weeks ago

$IART A rising tide lifts all boats, except those with holes in them.

User Image Stock_Titan Posted - 3 weeks ago

$IART Integra LifeSciences Completes the Acquisition of Acclarent, Inc. https://www.stocktitan.net/news/IART/integra-life-sciences-completes-the-acquisition-of-acclarent-c4iekq97jghs.html

User Image jjokerst Posted - 1 month ago

$IART dbl bottom pattern. Previous 3rd quarter E/R had a negative surprise @.77 p/s reported. Recent reported eps @ .89 p/s. Faced a recall, which booked an $81m decrease in cash flow: This is a transitory interference however we'll see how it impacts future revenue in the short term. I feel we’ll see this return to $40 range in coming months

User Image Villidj_Idjit Posted - 1 month ago

An updated $IART chart, this one a 6-month daily. Possible bullish divergence at the moment, but those signals work maybe half the time.

User Image Stock_Titan Posted - 1 month ago

$IART Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases https://www.stocktitan.net/news/IART/integra-life-sciences-launches-micro-matrix-r-flex-to-provide-qhbd0mk43d5q.html

User Image Aigner_Andreas Posted - 1 month ago

TD BUY $IART at 36.11, Supp 35.93 Resis 45.20 R26 HiLo INF% T1Y 54 hold 2.8 DIV N/A #Integra Li #stocks #trading #finance #market

User Image Villidj_Idjit Posted - 1 month ago

I would like to see $IART get down to $32.50ish.

User Image RiskVsReward Posted - 02/28/24

$IART Sometimes the stars are just aligning. 💥

User Image DonCorleone77 Posted - 02/28/24

$IART Integra LifeSciences CEO Jan De Witte to retire by the end of 2024 Integra LifeSciences announced that Jan De Witte has informed the Board of Directors of his intention to retire from his position as president and CEO of Integra following the appointment of a successor, which the company expects to occur by the end of 2024. The company also announced that Stuart Essig, Integra's chairman, has been appointed to the role of executive chairman, effective immediately. The Board has initiated a formal search for a new president and CEO and engaged Heidrick & Struggles to support the Board in identifying a highly-qualified candidate with a track record of industry leading profitability and growth and the development of inspired, high-performing teams.

User Image DonCorleone77 Posted - 02/28/24

$IART Integra LifeSciences sees Q1 adjusted EPS 53c-57c, consensus 74c Sees Q1 revenue $360M-$365M, consensus $380.89M.

User Image DonCorleone77 Posted - 02/28/24

$IART Integra LifeSciences sees FY24 adjusted EPS $3.15-$3.25, consensus $3.44 Sees FY24 revenue $1.603B-$1.618B, consensus $1.62B. "The company's guidance for 2024 revenue and adjusted earnings per share reflects the stability of our markets and strong demand for our differentiated portfolio, gradual improvement in supply over the year, continued international expansion and the relaunch of the Boston portfolio late second quarter. Our guidance excludes the pending acquisition of the Acclarent ENT business."

User Image DonCorleone77 Posted - 02/28/24

$IART Integra LifeSciences reports Q4 adjusted EPS 89c, consensus 90c Reports Q4 revenue $397M, consensus $399.34M. "In 2023, we saw stability in our markets and resilience of our product portfolio, which demonstrates the impact of our products and technologies on restoring patients' lives," said Jan De Witte, president and CEO. "Despite the operational challenges last year, I am extremely proud of our colleagues around the world for remaining focused on advancing our key pillars of growth and operational excellence, and for their unwavering commitment to our customers and patients."

User Image epsguid Posted - 02/28/24

$IART reported earnings of $0.89, consensus was $0.90 via @eWhispers #epsmiss http://eps.sh/d/iart

User Image Stock_Titan Posted - 02/28/24

$IART Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance https://www.stocktitan.net/news/IART/integra-life-sciences-reports-fourth-quarter-and-full-year-2023-r37dv3uf0qvc.html

User Image swingingtech Posted - 2 months ago

$ZG $IART $LOVE $KFFB https://wallstreetwaves.com/the-50-best-places-to-buy-a-home-for-under-250000/

User Image Stock_Titan Posted - 2 months ago

$IART Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024 https://www.stocktitan.net/news/IART/integra-life-sciences-to-host-fourth-quarter-and-full-year-2023-oc50iysf47xa.html

User Image Djheights Posted - 2 months ago

$IART

User Image cctranscripts Posted - 3 months ago

Integra LifeSciences Holdings Corporation's President & CEO just cashed-in 597 options https://www.conferencecalltranscripts.org/summary/?id=12880741 $IART

User Image shortvolumes Posted - 3 months ago

2024-01-12 Short sale volume (not short interest) for $IART is 61%. http://shortvolumes.com/?t=IART via @shortvolumes

User Image StockAutomatePro Posted - 3 months ago

$IART Not a bad time to buy chart analysis shows potential growth. We alerted the BUY signal at $41.61 and we were able to close this one with profit at $43.52 🎲

User Image shortvolumes Posted - 3 months ago

2024-01-05 Short sale volume (not short interest) for $IART is 78%. http://shortvolumes.com/?t=IART via @shortvolumes

User Image Stock_Titan Posted - 3 months ago

$IART Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference https://www.stocktitan.net/news/IART/integra-life-sciences-to-present-at-the-42nd-annual-j-p-morgan-2s1ad74x56j5.html

User Image KendineTrader Posted - 3 months ago

$IART zeksenlere çkkr. kendime not

User Image padd1 Posted - 12/28/23

$IART $skin can someone evalute if they benefit from the so called ozempic face? (More face beauty treatments becouse of sagging skin becouse of the weight loss)

User Image tickeron Posted - 12/26/23

A.I.dvisor made a bullish call on $IART, netting in a 10.04% gain over 2 weeks https://srnk.us/go/4952154

User Image fin_researcher Posted - 4 months ago

$IART investors have reasons to suspect Integra and its accountables for multiple misleading statements and failing to disclose real manufacturing issues at the Boston Facility. To claim compensation: https://11thestate.com/cases/integra-investor-lawsuit

User Image cctranscripts Posted - 4 months ago

ENTRY INTO A MATERIAL DEFINITIVE https://www.conferencecalltranscripts.org/summary/?id=12810562 $IART

User Image Last10K Posted - 4 months ago

$IART just filed with the SEC a New Agreement https://last10k.com/sec-filings/IART/0000917520-23-000082.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=IART

User Image risenhoover Posted - 4 months ago

$IART / Integra LifeSciences Holdings files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2023 INTEGRA LIFESCI https://fintel.io/doc/sec-integra-lifesciences-holdings-corp-917520-8k-2023-december-20-19711-9356?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Analyst Ratings
Citigroup Neutral Apr 3, 24
Truist Securities Hold Mar 1, 24
JMP Securities Market Outperform Feb 29, 24
Truist Securities Hold Dec 22, 23
Truist Securities Hold Dec 14, 23
JMP Securities Market Outperform Dec 14, 23
Wells Fargo Overweight Dec 5, 23
CL King Buy Nov 14, 23
Truist Securities Hold Oct 26, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
McBreen Michael J. EVP & President, CSS EVP & President, CSS Mar 07 Sell 54.2943 1,843 100,064 28,796 03/08/23
DAVIS ROBERT T. JR. EVP & President, TT EVP & President, TT Mar 01 Sell 55.21 1,566 86,459 45,920 03/03/23
DAVIS ROBERT T. JR. EVP & President, TT EVP & President, TT Mar 01 Option 26.87 1,566 42,078 47,486 03/03/23
Mosebrook Jeffrey SVP, Fin & Princ Acc.. SVP, Fin & Princ Acct Officer Dec 08 Sell 56.2162 279 15,684 8,552 12/08/22
Evoli Lisa Executive Vice Presi.. Executive Vice President &CHRO Aug 10 Sell 55.8108 1,165 65,020 17,997 08/11/22
Murphy Raymond G. Director Director Aug 05 Sell 55.7833 8,000 446,266 40,825 08/08/22
Mosebrook Jeffrey SVP, Fin & Princ Acc.. SVP, Fin & Princ Acct Officer Aug 02 Sell 56.775 437 24,811 8,831 08/03/22
Evoli Lisa Executive Vice Presi.. Executive Vice President &CHRO Jun 15 Sell 55.93 900 50,337 19,911 06/16/22
Tru St Partnership, L.P. 10% Owner 10% Owner Dec 16 Sell 64.92 300,000 19,476,000 8,515,930 03/25/22
McBreen Michael J. EVP & President, CSS EVP & President, CSS Mar 03 Sell 69 2,205 152,145 17,233 03/03/21
Arduini Peter J President & CEO President & CEO Dec 21 Option 15.79 45,000 710,550 261,713 12/21/20
Arduini Peter J President & CEO President & CEO Dec 21 Sell 61.97 45,000 2,788,650 216,713 12/21/20
Coleman Glenn Executive Vice Presi.. Executive Vice President & COO Nov 12 Sell 55.14 9,400 518,316 36,494 11/12/20